CAR Clinical Trials in Hangzhou, Zhejiang
164 recruitingHangzhou, Zhejiang, China
Showing 1–20 of 164 trials
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Triple-Negative Breast CancerEndometrial CancerPrimary Peritoneal Carcinoma+12 more
Genmab884 enrolled66 locationsNCT05579366
Recruiting
Phase 1
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines392 enrolled46 locationsNCT06427941
Recruiting
Phase 3
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Carcinoma, Non-Small Cell Lung
Mirati Therapeutics Inc.630 enrolled353 locationsNCT06875310
Recruiting
Phase 1
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
MelanomaNon-small Cell Lung CancerRenal Cell Carcinoma
Shanghai Henlius Biotech174 enrolled69 locationsNCT07160335
Recruiting
Phase 2
A Study of SKB518 in Patients With Lung Cancer
Lung Carcinoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.192 enrolled17 locationsNCT07019675
Recruiting
Phase 1Phase 2
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
Pancreatic CancerGastric CancerNon-small Cell Lung Cancer (NSCLC)+2 more
EMD Serono Research & Development Institute, Inc.250 enrolled81 locationsNCT06710132
Recruiting
Phase 3
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer MetastaticNon-Small-Cell Lung CarcinomaNon-small Cell Carcinoma
Pfizer680 enrolled305 locationsNCT07144280
Recruiting
Not Applicable
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China690 enrolled14 locationsNCT04937283
Recruiting
Phase 1
A Study of FZ-AD005 in Patients With Advanced Solid Tumors
Advanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.162 enrolled3 locationsNCT06424665
Recruiting
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
Gastric CancerCholangiocarcinomaPancreatic Carcinoma+3 more
Zhejiang University1,200 enrolled2 locationsNCT07359586
Recruiting
Phase 1Phase 2
Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy
Breast Adenocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University96 enrolled1 locationNCT06596018
Recruiting
Multi Omics Molecular Characteristics and Immunophenotyping of Lung Signet Ring Cell Carcinoma
Signet Ring Cell Carcinoma of the Lung
First People's Hospital of Hangzhou39 enrolled1 locationNCT07207278
Recruiting
Phase 2
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
Non-small Cell Lung CancerNasopharyngeal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.121 enrolled16 locationsNCT05956587
Recruiting
Phase 1Phase 2
Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation
Colorectal, CancerNon-small Cell Lung CancerKRAS P.G12C+1 more
Allist Pharmaceuticals, Inc.240 enrolled27 locationsNCT05288205
Recruiting
Phase 2
Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer
Breast Adenocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University74 enrolled1 locationNCT06671262
Recruiting
Phase 2
Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
Colorectal, CancerSquamous Cell Carcinoma of Head and NeckDLBCL - Diffuse Large B Cell Lymphoma+4 more
Zhejiang Provincial People's Hospital260 enrolled1 locationNCT06534762
Recruiting
Phase 4
Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
Triple-Negative Breast CancerCarcinoma BreastInvasive Ductal Carcinoma, Breast
Fudan University1,072 enrolled34 locationsNCT04790305
Recruiting
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Breast CancerLiver CancerColorectal, Cancer+10 more
Beijing Friendship Hospital2,700 enrolled4 locationsNCT06363123
Recruiting
Phase 3
The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
Cardiotoxicity Induced by Drug Therapy for Breast Cancer
Zhejiang Cancer Hospital276 enrolled1 locationNCT06214195
Recruiting
Phase 4
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study
Non-small Cell Lung CancerCarcinomaAdenocarcinoma
Tian Xie744 enrolled7 locationsNCT04401059